<DOC>
	<DOCNO>NCT00911196</DOCNO>
	<brief_summary>Hepatocellular carcinoma aggressive disease limit therapeutic option . Therefore , new approach treat type cancer need immunotherapy potentially one . As first step development novel therapy , expression analysis specific marker , include tumor antigen carry , correlation expression disease variables clinical outcome assess . This do retrospectively use archive hepatocellular carcinoma tissue sample .</brief_summary>
	<brief_title>Analysis Expression Specific Markers Their Prognostic Significance Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>The patient pathologically proven hepatocellular carcinoma ( stage ) All data require available patient 's record</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Prognosis</keyword>
	<keyword>Markers</keyword>
	<keyword>Expression analysis</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
</DOC>